who can postpone salvage radiotherapy in biochemically recurrent prostate cancer?
Published 2 months ago • 76 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
3:47
salvage radiotherapy in biochemically recurrent prostate cancer
-
2:53
use of salvage radiation therapy for biochemical recurrence of prostate cancer after prostatectomy
-
1:23
advances in salvage radiotherapy for prostate cancer
-
1:31
when is adjuvant or salvage radiotherapy beneficial in prostate cancer?
-
1:14
optimizing outcomes in psa recurrent prostate cancer
-
1:51
management of biochemical recurrence in prostate cancer
-
3:07
salv-enza: srt enzalutamide in high-risk psa-recurrent prostate cancer after radical prostatectomy
-
5:06
va starport prostate cancer clinical trial
-
2:26
managing biochemical relapse after radical prostatectomy
-
1:19
evaluating the role of salvage radiotherapy in prostate cancer
-
2:50
treatment recommendations for high-risk biochemical recurrent prostate cancer
-
4:16
psma pet guided salvage rt among patients with prostate cancer in the post-prostatectomy setting
-
5:51
plan b: salvage treatment for prostate cancer
-
1:33
formula-509 rationale trial design: the addition of aap apa post-radical prostatectomy
-
45:58
winship grand rounds august 30, 2017: alan pollack, md, phd
-
2:10
genomic prognostics for prostate cancer salvage radiotherapy
-
2:24
spport: adt and salvage radiotherapy in prostate cancer
-
1:01
dr. einstein on biochemical recurrence in prostate cancer
-
1:44
results of the phase iii pcs5 trial of hypofractionated radiotherapy for prostate cancer